Alpha DNA Investment Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-3,732
| Closed | -$430K | – | 235 |
|
|
2024
Q3 | $430K | Buy |
+3,732
| New | +$430K | 0.16% | 158 |
|
|
2023
Q4 | – | Sell |
-4,993
| Closed | -$562K | – | 213 |
|
|
2023
Q3 | $562K | Buy |
+4,993
| New | +$562K | 0.23% | 105 |
|
|
2023
Q1 | – | Sell |
-9,623
| Closed | -$1.15M | – | 180 |
|
|
2022
Q4 | $1.15M | Buy |
9,623
+4,195
| +77% | +$501K | 0.41% | 61 |
|
|
2022
Q3 | $576K | Buy |
+5,428
| New | +$576K | 0.48% | 86 |
|